July 31, 2026 · Public Services, Science & Humanitarian Impact

Well supported

Trump Administration Rewrites Its 340B Pilot to Let Drugmakers Pay Hospitals Back Instead of Discounting Up Front

The Health Resources and Services Administration on July 31 issued revised terms for a pilot program under the 340B Drug Pricing Program that would allow some drugmakers to provide rebates after a purchase rather than...

April 2, 2026 · Economy, Trade & Fiscal Policy

Confirmed

Trump Imposes Tariffs of Up to 100% on Imported Brand-Name Drugs, With Broad Exemptions

On April 2, 2026, the Trump administration imposed tariffs of up to 100 percent on imported branded and patented pharmaceuticals produced by drugmakers that had not reached agreements with the United States to lower...

December 21, 2025 · Economy, Trade & Fiscal Policy

Confirmed

Trump Announces Most-Favored-Nation Drug Pricing Deals With Nine Pharmaceutical Companies

On December 19, 2025, Trump announced pricing agreements with nine major pharmaceutical companies, including Amgen, Bristol Myers Squibb, Merck, GSK, Novartis, and Sanofi, tying U.S. prices for certain drugs to the...

October 7, 2025 · Corruption, Ethics & Self-Dealing

Well supported

Trump Jr.'s BlinkRx Board Seat Aligns with Administration's Drug Pricing Push

After President Trump sent letters on July 31, 2025 urging 17 pharmaceutical CEOs to sell drugs directly to consumers, BlinkRx, a digital pharmacy company where Donald Trump Jr. sits on the board, launched a service...